RecruitingNot ApplicableNCT05417334
Effect of Radiofrequency in the Treatment of de Novo Dyspareunia at 4 to 16 Months Postpartum.
Effect of Radiofrequency in the Treatment of de Novo Dyspareunia at 4 to 16 Months Postpartum: Randomised Prospective Trial
Sponsor
Hospital Clinic of Barcelona
Enrollment
110 participants
Start Date
Mar 18, 2021
Study Type
INTERVENTIONAL
Conditions
Summary
This study evaluates if the application of resistive capacitive monopolar radiofrequency therapy associated with Thiele massage is effective when treating de novo dyspareunia at 4 to 9 months postpartum.
Eligibility
Sex: FEMALE
Inclusion Criteria4
- -9 postpartum
- de novo dyspareunia after delivery
- obstetric injury
- Grant informed consent
Exclusion Criteria6
- radiofrequency contraindications (pacemaker, active infection or pregnancy)
- cesarean section
- dyspareunia previous to labour
- previous vulvo-vaginal pathology
- patients with postpartum depression
- patients with a pelvic region oncological history
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEResistive Capicitive Monopolar Radiofrequency
5 Radiofrequency sessions including the abdominal region, the vulva and pelvic floor tissue and Thiele massage done daily by the patient at home
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05417334
Related Trials
Effectiveness of Radiofrequency Combined With Ultrasound for the Treatment of Postpartum Dyspareunia
NCT075049911 location
Changes in the Impact of Genitourinary Syndrome of Menopause With a Novel Nonhormonal Vulvovaginal Gel Assessed by PROMs.
NCT069623451 location
Pre-Rehabilitation for Female Patients Undergoing Pelvic Radiotherapy
NCT060595863 locations
Effectiveness of a Telerehabilitation Program for Improving Sexual Function and Reducing Pain in Menopausal Women
NCT067100021 location
VIBRating vs Traditional Therapy for Treatment of ENTry Dyspareunia
NCT068403141 location